The animal health care market in the world has grown remarkably over the past few years due to the growth in the emerging markets such as China, India, Indonesia, Thailand, Malaysia and Taiwan followed by US and Europe. The animal health industry’s SWOT analysis provides animal health solutions to society depends on its in-depth knowledge of both cutting-edge technologies and classical veterinary science to innovate and keep up with the animal and human health challenges of new and emerging diseases. The main finding of this project indicates India is one of the important markets and can be seen as a key growth area in global animal health care industry. - The Indian animal healthcare industry is responsible for maintaining the health and productivity of the over 640 million livestock and 2 billion poultry in India and ensuring the wholesomeness and abundance of the food they produce. Apart from, the industry must also cater to the health and well being of companion animals. Despite this, the global animal healthcare market is 50 times larger than the Indian animal healthcare combined market for all nonhuman species. In spite of this India’s largest milk and 3rd largest meat producer, and blessed with largest cattle population 20% of the world population, and largest buffalo more than 50% of the world. Veterinary Pharmaceutical is yet not considered as big industry as compared to Human Pharmaceutical. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development and innovation, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. The situation in developing countries like India is varied and economic and institutional framework of the live stock is often quite different in several respects to that encounter in developed world. A challenging aspect of the overall market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Indian consumers are becoming more health conscious, willing to pay any amount and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.

1. Title:-Animal Health Care Industry in India: An analysis of Strength, Weakness,
Opportunity and Threats
K.S.Niranjan
(Senior Researcher & Consultant at Public &
Private Value Added Marketing

2. Cattle
1400
Buffalo
195
Poultry
22000
Goat
875
Sheep
1043
Pigs
963
Pets
260
Source: FAOSTAT
World Livestock Population (in Mn. Heads)-2011
2K.S.Niranjan

3. 0
5000
10000
15000
20000
25000
Global Animal Healthcare Market :2005-2011
2005 2006 2007 2008 2009 2010 2011
Year
USDMillion
3
K.S.Niranjan

4. North America
33%
Latin America
14%
Europe
32%
Asia-Rest of
World
21%
Total Market: 22 Billion USD
Geographical Segmentation: Global Animal Health Market-2011
4
K.S.Niranjan

5. 62%
Pharmaceutical
26%
Biologicals
12%
Medicinal Feed
Additive
Global Animal Healthcare Market by Product:2011
•Anti-infective
•Paraciticides
•Others
5
K.S.Niranjan

6. 60%
Food
Animals
40%
Companion
Animal/
Others
-Cattle
-Poultry
-Pigs
-Sheep
-Goat
Global:- Species-wise Market Share: 2011
6
K.S.Niranjan

7. Companion
Animal
39%
Ruminants.
30%
Swine.
18%
Poultry
11%
Aquaculture
2%
13%
Global Animal Health Market -(22Bn)
Global Animal Healthcare Market by Species:2011
7
K.S.Niranjan

8. 0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
2007 2008 2009 2010 2011
Global AH Market trend: 2007 to 2011
Companion Animals Cattle Pigs Poultry Sheep Aqua
Sales in Mn.USD Source: Vetnosis
8K.S.Niranjan

9. Company Revenue-2011( $ Mn.) % share Growth %
Over 2010
Pfizer Animal Health Ltd. 4170 18.9 8.7%
Merck 3195 14.5 10.6%
Sanofi Aventis (Merial) 2783 12.7 7.4%
Elanco 1729 7.9 13.1%
Bayer Healthcare 1500 6.8 7.4%
Boehringer Ingelheim 1319 6.0 11.8%
Novartis 1187 5.4 7.0%
Virbac 811 3.7 12.5%
Ceva 740 3.4 12.3%
Vetoquinol 398 1.8 4.3%
All others 4260 19.4 11.3%
Total 22092 100.0 9.7%
Market Share of Major Players of Global Animal Healthcare Industry -2011
9K.S.Niranjan

10. Pfizer 18.9%
Merck
14.5%
Merial
12.6%
Elanco 7.8%
Bayer
6.8%
Boehringer
6%
Novartis
5.4%
Virbac 3.7%
Ceva 3.3%
Vetoquinol 1.8%
All others
19.3%
MarketShare
GlobalAnimal
HealthcareCompany
10
K.S.Niranjan

11. Mega
Trends
$ 22 billion Market in 2011
7% CAGR ( 2005-2011)
Growing global affluence drives protein consumption.
Continuing growth in largest segment companion animals.
 The general trend in animal health is towards quality, safer
and more efficacious products.
Growth
Drivers
Focus R&D investment on innovation and state of the-art
&science.
 Capitalize on rapid growth of companion animals segment
and geographical expansion in developing nations.
Transformation from many disease control and prevention
through bio-security and usage of biological products.
Global Animal Healthcare Market:
Snapshots
11K.S.Niranjan

12.  AHC
Industry
Highly
Fragmented
 Largest
Animal
population
Heads.
 Large
Untapped
Potential
 Political
factors
Moderately
favourable
 Economic
condition
poor
 Used
traditional
medicine
 Superstitiou
s belief
 Companion
animals &
aqua
segment set
to grow
 Trend of
therapeutics
and
Medicinal
feed
Supplement
 Price
Competitive
 Copy cat
Brands
 Regional
Players in
Many
Products
 Moderate
competition
 Emergence
of new
Diseases
 Entrance of
MNC
 Expansion
of Field
Force
 Awareness
Campaign
Market
Structure
Long Term
Trend
Majors
Growth
Drivers
Evaluate
• Strengthen
the Rural
Markets
• Diverse
products
Portfolio
• Optimal
Utilization of
Human
Resources
Environmental
Scanning
Future
Objective &
Strategies
Intensity of
Competition
Conceptual
Framework
Indian Animal
Healthcare
12
K.S.Niranjan

13. Conceptual
Framework
Indian
AHC
1
2
3
4
6
5
Market Structure
• Highly Fragmented, Untapped
• Largest Animals Population
heads
1
Environmental Scanning
• Political factors: Moderate
• Economy: Poor, Traditional
Medicine, Superstitious
2
Long Term Trend
• Therapeutics, Feed Supplement
• Pets & Aqua Segment
3
Competition Intensity
• Price: Competitive, Copy Cat
Brands, Moderate competition
• Regional Players,
4
Majors Growth Drivers
• Emerging New Diseases
• MNC,Field force Expansion
5
Future Objectives & Strategy
• Strengthen Rural Market
• Diverse Products Portfolio
• Optimal Utilization of HR
6
13
K.S.Niranjan

14. Indian
Animal
Healthcare
Market
14K.S.Niranjan

15. Cattle
210
Buffalo
113
Poultry
968
Goat
157
Sheep
75
Pigs
9.5
Pets
14
Aqua-80,000
Hectares
Source: FAOSTAT
Indian Livestock population: 2011(in Million Heads
15K.S.Niranjan

16. Sheep-75 Million Heads
Goat-139 Million Heads
Pigs -26 Million Heads
Pets-14 Million Heads
India Biological Market:2011
Source: Complied from
CLFMA, Govt. of India, American
Soya bean Association
Total Cattle: 592 Million Heads
16
K.S.Niranjan

17. 9%
5%
35%
10%
12%
8%
7%
0%
5%
10%
15%
20%
25%
30%
35%
40%
0
5000
10000
15000
20000
25000
2005 2006 2007 2008 2009 2010 2011
Rs.Million
Years
Indian Animal Healthcare Market Growth 2005-2011
%Growth
17
K.S.Niranjan

18. GrowthSales(Rs.Mn)
Years 18
K.S.Niranjan

19. Pharmaceuticals
46%
Medicinal feed
Additive
26%
Biological /Bio-
Security
28%
Indian Animal Health Market By Products- 2011
0
2000
4000
6000
8000
10000
12000
10050 5800 6150
Market(Rs.Mn)
19
K.S.Niranjan

20. Indian Animal Healthcare Market by Segment :2011
Cattle
51%
Poultry
36%
Companion
Animal
6%
Aqua
4%
Sheep & Goat
3%
0
2000
4000
6000
8000
10000
12000
11220
7920
1320 880 660
Cattle Poultry Companion Animal Aqua Sheep & Goat
Market Share in (mn.INR)
20K.S.Niranjan

21. 0
2000
4000
6000
8000
10000
12000
2007 2008 2009 2010 2011
SalesinMillionINR
Indian Animal Health Market Trend: 2007 to 2011
Cattle Poultry Companion Animal Aqua Sheep & Goat 21K.S.Niranjan

22. Shift towards increase milk production
Focus on cross breeds & high yielding animals
Professionalization of poultry industry, treating
to prevention
Advance feed production Pelleted to Global std.
Changing structure of farming more towards
integration
Willingness of pet owner to spend more on their
health
Development of growing Aqua (fisheries) segment
Emerging Trend: India
AHC
22
K.S.Niranjan

23. Pfizer Animal Health
Virbac Animal Health(I) Pvt. Ltd.
Venky,s India Ltd
Provimi Animal Nutrition (I) Pvt.Ltd
Zydus Animal Health
MSD Animal Health I Pvt. Ltd
Intas Pharmaceuticals Ltd
Alembic Veterinary
Novartis Animal Health
Vetoquinol Animal Health
Top 10 Major Players in Indian Animal Healthcare Industry 2011 (Not Ranked)
23
K.S.Niranjan

24. GLOBAL
Species-wise
Pharmaceuticals
62%
Biological
26%
Feed Additive
12%
Products
INDIA
Cattle 52%
Poultry 37%
Pets 6%
Others 5%
Species-wise
Pharmaceuticals
46%
Biological/
Bio-security
28%
Feed Additive
26%
Products
Cattle 30%
Pets 39%
Poultry 11%
Swine 18%
Aquaculture 2%
Glocal Animal Health Market:2011
24
K.S.Niranjan

25. 0
5000
10000
15000
20000
25000
30000
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Sales ( Rs.million)
India Animal Health Market Estimated Sales: 2006-2015
25
K.S.Niranjan

26. Livestock industry contributes 6% to GDP next to
agriculture
2nd largest contributor to GDP – the future food
factory of the world
India is world largest milk produced 122 million
ton.
Poultry 3rd largest egg and meat producers in the
world
Ranks 4th in Sheep & 6th in Fish production in the
world
Has 58% of World buffalo heads.
Per capita consumption levels
Milk: 265 gm
Tgt: 400 gm
Meat: 2.6 kg
Tgt: 3.5 kg
What's Makes India
Attractive
pet owners to spend more on the health of the
animals
26
K.S.Niranjan

27. Concern (Main Barrier) of Indian Animal HealthCare Industry
Lack of Official Market Data
Lack of linkage between industries and academician for
marketing research and advance drugs discovery
Lack of Growth : Value Vs Volume
Unethical Marketing Practices
Low Export Opportunity
Direct Selling by Sales Staff/ Handling Cash
High Attrition Rate of the Sales personnel's
Very High Territory Development Cost
Varying Customers Perception
No New Products (Copy Cat Branding)
Classification of Feed Supplements
(No Stringent Law)
Unclear Value of Rx from Veterinarian/Para/Customers
High WC: Cattle: 21 - 120 days, Poultry : >120 days
Parallel Manufacturing & Marketing by 3rd party
Formulators
27
K.S.Niranjan

28. PEST Analysis: India Animal Healthcare Industry
Socio-cultural Factors
Poverty and associated inadequate nutrition
exacerbate the incidence of many disease.
India farmers prefer using household treatments
handed down for generations for common
ailments.
The use of magic/tantrics/ozhas/hakims is
prevalent in India.
Ignorance of inoculation and vaccination has
prevented the eradication of diseases like
FMD,HSBQ,Anthrax,RD,IBD and others.
Superstitious beliefs and any sort of ailment is
Political Factors
Industry threatening to impose even more
stringent price control.
DPCO nullifies the market forces from
encouraging competitive pricing of goods
dictated by the market.
2005 the country goes in for the IPR (Intellectual
Property Rights)regime, popularly known as the
Patent Act.
Excise Duty on the cost of manufacturing to the
MRP thereby making the finished products more
costly.
Subsides in specific area, others place are not
suitable for Mfg.
Technological Factors
Advanced automated machines have
increased the output and reduced the cost.
Computerization has increased the efficiency
of the animal Pharmaceuticals Industry.
Ayurveda is a well recognized science and it is
providing the industry with a cutting edge.
Advances in Bio-technology, Biological
research have given India a step forward
Economic Factors
Customers spend a very small proportion of
its income on animal health, until severely
sick.
Per capita income of farmers is very low.
The incidence of Taxes are very high. There is
Excise Duty (State & Central), Custom
Duty, Service Tax, Profession Tax, License
Fees, Royalty, Pollution Clearance
Tax, Hazardous substance (Storage &
Handling licenses) income tax.
High interest rate regime cost of funds is
double
Adequate storage and transportation facilities
for animal health drugs is lacking.
Poor infrastructure like roads & rail network
28
K.S.Niranjan

29. Porter’s Five Forces Model(AHC)
29
K.S.Niranjan

30. Porter’s Five Force Analysis: India Veterinary
Pharmaceuticals
– Bottlers
INDUSTRY
COMPETITORS
Rivalry among
existing firms
BUYERS – High, Moderate
• In oral nutritional supplement the buyer
power is very high, implying strong
downward pressure on prices
•The treatment products such as
antibiotics which is prescribed by
veterinarian leads to compulsion for buyer.
•Switching cost is somewhat low
•Rivalry between one company to another
is heavily severe.
•processes are similar as human
pharma, creating similar high costs to
develop and release new drugs.
ENTRANTS -Moderate
•Primary threat for entrance from generic
drug.
• Making products available to all the
retailers is hard and time taken.
•Animal drug competition is less
susceptible to generic influence except
some oral supplement as well as nutritional
products.
• Large economies of scale that create high
barriers to entry. Small scale start-ups
require a large amount of capital and face
many risks,
SUBSTITUTES - High
•Retailers can be easily replaced by other
products.
• Generic manufacturer and local company
create substitute for pioneer drugs, these
represent a copy cat strategy in feed
supplement and anthelmintics.
• High margin and high promotional
discount is also another reason for
substitutes.
• In pets products and biological products
there is less substitute as compare to large
animal products.
SUPPLIERS - Moderate
• Feed Supplement- Low
• Therapeutic- Moderate
•Biological & Hormonal preparation- High.
•The animal health industry is a primary
manufacturer and has few and diversified
suppliers.
• Some chemical and other ingredients
used by pharmaceuticals company has
very high quality standard ,this can lead to
a form of market power so there are
relatively few supplier of a products who
can provide those quality assurance
Bargaining
power of
suppliers
Threat of
new entrants
Bargaining
power of
buyers
Threat of
substitutes
30K.S.Niranjan

31. Porters Five Forces Model:- Indian Animal Healthcare Industry
Buyer Power: High, Moderate
Buyers: Stockist,Retailers, Veterinarian, Dairy & Poultry
Farmers
Medicinal feed supplement the buyer power is very high.
•In Therapeutics, customers have very little bargaining
power. Most of the medication is prescribed by the Vet.
practitioners. Customers will have to buy the drug at
any given price if they need it.
More educated customers may buy a generic alternative
(which have the same impact but less expensive) if
available in the market.
Switching cost is somewhat low and customer can
easily switch from one products to another cost
effective products, with the influence of the retailers.
Retailers buyer power is very high, because of the
regional company and some new entrants who offer
high promotional discount and credit facility to make
availability of the products.
Governments in most of the state are generally the
important customers, and therefore, enjoy substantial
pricing leverage.
Pricing pressure – The India remains one of the few
developing markets where drug manufacturers have
significant pricing flexibility, and this is in jeopardy due
to increasing pressures from consumers and legislators
to control health care costs.
Bargaining Power of
31K.S.Niranjan

32. Supplier Power: Moderate
Suppliers: Chemicals, Raw materials, Bulk Drugs
Medicinal Feed Supplement-Low
Therapeutics- Moderate
Biological & Hormonal-High
There are few supplier because of less number of
companies in the market.
The Switching cost is high then company cant easily
switch from one to another's
The product is not standardized so that they don’t
have many choices.
Animal healthcare industry is a primary manufacturer
and have few & diversified suppliers.
Some chemical and other ingredients used by
pharmaceuticals company has very high quality
standard ,this can lead to a form of market power so
there are relatively few supplier of a products who can
provide those quality assurance.
Suppliers generally have little room for negotiation.
Large AH pharmaceutical companies generally enjoy
significant buying power.
Bargaining Power of
32
K.S.Niranjan

33. Substitutes Power: High
The switching cost is low.
Customers can find substitute medicine if
the original product is more expensive.
However, if it is a new product the
consumer generally will have no choice for
an alternative.
Retailers can be easily replaced by
other high margin products.
Generic manufacturer and regional players
create substitute for pioneer drugs, these
represent a copy cat strategy in feed
supplement and anthelmintics.
High margin and high promotional discount is
also another reason for substitutes. In Pets
products and Biological products there is less
substitute as compare to large animal products
Threats of
33
K.S.Niranjan

34. Threats of New Entrants: Moderate
Primary threat of entrance from regional
company as well as generic.
Very low barrier to entry
Govt. Policy supportive(100% FDI)
Making products available at all the retail
outlets is expensive and time taken.
Animal drug competition is less susceptible to
generic influence except some oral supplement
as well as nutritional products.
Large economies of scale that create high
barriers to entry. Small scale start-ups
require a large amount of capital and face
many risks
Heavy invest capital required
Threat of
34
K.S.Niranjan

35. Highly competitive top 10 players have
mere 80% market share
The exist barriers are very high
Industry growth is slow and time taken.
Lower fixed cost and high working
capital
Rivalry between one company to
another is heavily severe.
Processes are similar as human
pharmaceuticals, creating similar high
costs to develop and release new
drugs.
Huge competition based on the price of
the product among the various
companies
Competitor Rivalry: High
35K.S.Niranjan
Competitors

36. SWOT Analysis: Indian Animal Healthcare
Industry:
Strength
Animal healthcare drugs are similar to human
pharmaceuticals drugs and no specialized
machinery is required for manufacturing them.
Sizeable population of high yielding cows and
buffalo; large domestic market for milk and milk
products.
Animal-health research and development is much
faster, less expensive and more predictable than
human pharmaceuticals.
India’s large number of
9527 Veterinary Hospitals/Polyclinic
20897 Veterinary Dispensaries,
24482 Veterinary Aid Centre/Mobile dispensaries,
335 Disease Diagnostic Labs
28 Veterinary Vaccines Production Units.
36K.S.Niranjan

37. India with a largest animal population heads is a
largely untapped market.
The penetration of animal health products is less
than 15% in India.
Indian manufacturer are one of the lowest cost
producers of drugs in the world, drug
manufacturing in India is up to 50 percent
cheaper than in western industrial countries, and
well developed industry with strong
manufacturing base.
Animal healthcare companies promotional
strategy is based on direct contacts with
customer like dairy farmers, poultry farmers and
indirect selling through veterinarians, livestock
supervisor etc.
Animal drug competition is less susceptible to
generic influence except some oral supplement
as well as nutritional products. 37
K.S.Niranjan

38. There is no any stringent law for nutritional products so
that most of the mall practices are using by the regional
and local player.
Distribution channel are highly fragmented, difficult to
make availability of products and increasing
distribution costs for animal health products.
Industry is highly dependence on import from China
due to unmatched costs of power and high capacity
build up leading to low cost of production.
Inadequate Infrastructure like power, roads and cold
chains lack of advance labs and related infrastructure
for drug testing and appropriate treatment method.
There is a conspicuous lack of strong linkage between
industries and academician for marketing research and
advance drugs discovery.
Low capability and motivation for cutting edge
research, diagnosis labs, drug sensitivity and platform
Weakness
38
K.S.Niranjan

39. Fragmented nature of cattle population mostly non-
descript animals in rural India, it’s more expensive to
penetrate the market by the sales force and time
taken, which increase the sales and distribution costs to
the animal health companies.
Price Regulation-Reduce the pricing ability of
companies, leads to lower profitability for the companies.
Lack of products patent-prevent global pharmaceuticals
companies to introduce new drugs in the country, but this
has provided on upper hand to the Indian
pharmaceuticals companies.
Very low barrier to entry , animal healthcare pharma is
highly fragmented, leads to increasing competition and
price competitive.
Negligible expenditure on animal healthcare research &
development.
Lack of appropriate marketing research before
39
K.S.Niranjan

40. Key opportunities for growth are the willingness of
pet owners to spend more on the health of their
animals and the ability of veterinarians to meet that
need.
Very lucrative high profit making market with the
high chances of growth, increase awareness among
people about nutrition, vaccination, bio-
security, animal health and productivity.
Future trends include product development for
growing segments like parasitic ides and biological
products for companion animals, increased
shopping at retail outlets and through internet and
over-the-counter (OTC) products posing stiff
competition to prescription.
The professionalization of poultry
industry, changing focus of farmers from treating to
preventing disease are other factors will drive
Opportunities
40
K.S.Niranjan

41. Emergence of new diseases, changes in animal
production practices, high yielding cattle’s and
new product introductions and ongoing food
safety concerns.
The companion animal and Aqua (fisheries)
segment would be tomorrow market, while
poultry will remain at the centre of animal health
industry, as the functional food market is likely
to grow in India.
Frequent outbreaks of animal diseases such as
avian influenza, anthrax, and other viral and
bacterial infections, animal healthcare
companies has gained tremendous significance
across the Indian Territory.
There is a large unorganized sector, estimated
at Rs 40,000 million, comprising regional
players and local importers of animal health
products from others Asian countries.
Opportunities
41K.S.Niranjan

42. Increasing the feed cost of poultry as well as
cattle, and inflationary pressure continue to be
areas of concern.
Inadequate infrastructure and cold storage
facilities, impact prospects for export and cause
price fluctuation in the poultry segment.
Marketing in the village include some unplanned
taxi tour and non availability of public/ private
transport as well as travelling by two-wheeler is
highly expensive to the companies.
Poorly educated rural population, lack of adequate
qualified veterinarian, lack of awareness of ailments
or symptoms, cultural gaps in urban marketers and
rural dairy farmers, scant availability of marketing
research.
Increase competition to country like India from
emerging manufacturer in China and east Europe
Threats
42K.S.Niranjan

43. and not increasing the milk, eggs and meat in the same
manner as compare to feeds and drugs.
High cost of sales and marketing, competition
particularly from regional players in the feed
supplement products.
Unregulated competition from generics as well as
local and regional veterinary pharmaceuticals
companies.
Diversion from dairy farming, poultry farming to
agri-business nearby tier-2 & tier-3 cities due to
increase the land prices.
Drug Price Control Order puts unrealistic ceiling on
product prices and profitability and prevent
veterinary pharmaceuticals companies from
generating investible surplus.
The uncertainty in the pricing policy ( Governed by
the national pharmaceuticals pricing committee % 43
K.S.Niranjan

44. Integration
Merger &
Acquisition
New
Product
Line
Increase
Pet owner
Awareness
Consistent Animal
healthcare Market
Size
Market
Size
2007 2011+
44
K.S.Niranjan

45. Current Situation
Demanding customers
Unethical Marketing
Practices
Proliferation of Generics
Price War
Customer Knowledge >
Sales Force
Target
Branding & Marketing
Excellence
Strong Brand & Product
Range
 Efficiency in Procurement to
Compete Generics
 Vaccines, Bio-security & New
Drug Delivery System
Current Situation Holding From Reaching
the Target
45
K.S.Niranjan

46. (Medicinal Feed
Supplement, Antibiotics &
Antiparaciticides)
(Bio-security/
Preventive products
(Biological,
Hormonal Products)
(Rumen-tonics/DPCO Products/
Others)
Low
HighLow
High
Invest
Select a Few Remainder
Divested
Liquidate
Market
Growth
Market
Share
BCG Matrix: Indian Animal Healthcare Industry
Star
Dog
46
K.S.Niranjan

47. THANK YOU
47
K.S.Niranjan

48. 48
K.S.Niranjan